Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12875 ◽

2017 ◽

Vol 19 (5) ◽

pp. 754-758 ◽

Author(s):

Linong Ji ◽

Ling Li ◽

Jian Kuang ◽

Tao Yang ◽

Dong-Jun Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Efficacy And Safety ◽

Phase 3 ◽

Asian Patients ◽

Dose Combination

Download Full-text

Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13491 ◽

2018 ◽

Vol 21 (1) ◽

pp. 103-111 ◽

Author(s):

Ji Cheol Bae ◽

Kyung Wan Min ◽

Yong Hyun Kim ◽

Kyoung-Ah Kim ◽

Eun-Gyoung Hong ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Dose Combination

Download Full-text

Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0030-1265174 ◽

2010 ◽

Vol 119 (02) ◽

pp. 63-68 ◽

Author(s):

N. P. E. Kadoglou ◽

A. Kapelouzou ◽

H. Tsanikidis ◽

I. Vitta ◽

C. Liapis ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Metformin Monotherapy ◽

Dose Combination ◽

Download Full-text

Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

Value in Health ◽

10.1016/j.jval.2016.09.1844 ◽

2016 ◽

Vol 19 (7) ◽

pp. A667

Author(s):

I Daacke ◽

S Kanters ◽

K Thorlund ◽

A Tebboth

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Relative Efficacy ◽

Efficacy And Safety ◽

Dose Combination

Download Full-text

Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.2010.505235 ◽

2010 ◽

Vol 19 (8) ◽

pp. 1017-1025 ◽

Author(s):

Clifford J Bailey ◽

Brian D Green ◽

Peter R Flatt

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Dose Combination

Download Full-text

Fixed-Dose Combination Therapy in Type 2 Diabetes Mellitus

Endocrine Practice ◽

10.4158/ep14259.ra ◽

2014 ◽

Vol 20 (12) ◽

pp. 1322-1332 ◽

Author(s):

Lawrence Blonde ◽

Zinnia T. San Juan ◽

Peggy Bolton

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Dose Combination

Download Full-text

Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13496 ◽

2018 ◽

Vol 21 (1) ◽

pp. 136-145 ◽

Author(s):

Kohei Kaku ◽

Masakazu Haneda ◽

Yuko Tanaka ◽

Ganghyuck Lee ◽

Kosuke Shiki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Safety Profile ◽

Controlled Trial ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Efficacy And Safety ◽

Dose Combination

Download Full-text

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2011.02749.x ◽

2011 ◽

Vol 65 (9) ◽

pp. 930-938 ◽

Author(s):

A. Pérez-Monteverde ◽

T. Seck ◽

L. Xu ◽

M. A. Lee ◽

C. M. Sisk ◽

...

Keyword(s):

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Efficacy And Safety ◽

Dose Combination ◽

Download Full-text

Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13352 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2200-2209 ◽

Author(s):

Ryuzo Kawamori ◽

Masakazu Haneda ◽

Keiko Suzaki ◽

Gang Cheng ◽

Kosuke Shiki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Safety Profile ◽

Controlled Trial ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Efficacy And Safety ◽

Dose Combination

Download Full-text

Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2006.00648.x ◽

2006 ◽

Vol 8 (6) ◽

pp. 643-649 ◽

Author(s):

J. Rosenstock ◽

J. Rood ◽

A. Cobitz ◽

C. Huang ◽

A. Garber

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Poor Glycaemic Control ◽

Dose Combination

Download Full-text

Comparison of Persistence and Adherence Between Fixed-Dose Combination Therapy and Two-Pill Combination Therapy in Japanese Patients with Type 2 Diabetes Mellitus Using Two Administrative Databases

Value in Health ◽

10.1016/j.jval.2018.07.010 ◽

2018 ◽

Vol 21 ◽

pp. S1

Author(s):

A Oh ◽

H Katou ◽

K Kisanuki ◽

Y Onishi ◽

F Guelfucci ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Administrative Databases ◽

Dose Combination

Download Full-text